Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de David M. Tanen
Age : 49
Public asset : 12,418,039 USD
Linked companies : Kronos Bio, Inc. - Allogene Therapeutics, Inc.
Summary 
Founder of 6 different companies, including: Kite Pharma, Inc., Allogene Therapeutics, Inc. and Arno Therapeutics, Inc. David M. Tanen is an entrepreneur and currently holds the position of Director, Vice President & Managing Member at Two River Group Management LLC, Partner at Two River Group Holdings LLC (which he founded in 2011), Director & Senior Managing Director at Riverbank Capital Securities, Inc. (a subsidiary of Two River Group Holdings LLC), Secretary at Allogene Therapeutics, Inc. (which he founded in 2007) and Secretary & Director at Neogene Therapeutics, Inc.

He is also on the board of Danube Pharmaceuticals, Inc. and Kronos Bio, Inc. and Director & Senior Managing Director at Riverbank Capital Securities, Inc., Managing Member at Two Rivers Consulting Corp. and Partner at Two River Consulting LLC (he founded the company).

Mr. Tanen previously was Secretary & Director at Arno Therapeutics, Inc. (he founded the company in 2000) and Secretary for Arno Therapeutics, Inc. (a subsidiary of Arno Therapeutics, Inc.), Secretary at Capricor Therapeutics, Inc. and Secretary at Nile Therapeutics, Inc. (a subsidiary of Capricor Therapeutics, Inc.), General Partner of Orion Biomedical Fund LP and Secretary & General Counsel for Kite Pharma, Inc. (he founded the company).

Mr. Tanen received an undergraduate degree from George Washington University and a graduate degree from Fordham University School of Law.


Current positions of David M. Tanen 
NameTitle Since
Kronos Bio, Inc.
(Biotechnology & Medical Research)
Director -
Allogene Therapeutics, Inc.
(Biotechnology & Medical Research)
Secretary -
Riverbank Capital Securities, Inc. Director & Senior Managing Director 2013
Danube Pharmaceuticals, Inc. Director 1996
Two River Group Management LLC Director, Vice President & Managing Member -
Neogene Therapeutics, Inc. Secretary & Director 2018
Kirax Corp. Co-Founder 2005
Two Rivers Consulting Corp. Managing Member -
Two River Consulting LLC Partner -
Two River Group Holdings LLC Co-Founder & Partner 2011


Holdings of David M. Tanen 
NameEquities%Valuation
Kronos Bio, Inc. (KRON)
(Biotechnology & Medical Research)
913,7631.62%12,418,039 USD


David M. Tanen: Personal Network 
Most Read News 
01/18ELON MUSK : Tesla investors urge judge to order Musk repay $13 billion for SolarCity deal
RE
01/14ELON MUSK : Musk says Tesla to accept dogecoin for merchandise
RE
01/27ELON MUSK : human-like robots and self-driving cars
RE
01/20ALAN JOPE : Unilever strategy under scrutiny after short-lived GSK skirmish
RE
01/27BERNARD ARNAULT : LVMH has pricing power to counter inflation, but must be reasonable-Arnault
RE
01/24ELON MUSK : Tesla countersues JPMorgan, claims bank sought 'windfall' after Musk tweet
RE
01/23NELSON PELTZ : Nelson Peltz's Trian builds stake in Unilever - source
RE
01/28CATHIE WOOD : Cathie Wood's ARK buys the dip in Tesla shares after months of selling
RE
01/26WILLIAM ACKMAN : Ackman's Pershing Square takes new position in Netflix
RE
01/25JOHN HESS : Hess Corp sees higher capital spending, production in 2022
RE
More news


© 2022 People and Ownership :   
David M. Tanen : Connections